A retrospective analysis of disability and its related costs among employees with chronic obstructive pulmonary disease

Journal of Occupational and Environmental Medicine

Volumn 49, Issue 1, 2007, Pages 22-30

  Darkow, Theodore ^a,d   Kadlubek, Pamela J ^a   Shah, Hemal ^b   Phillips, Amy L ^b   Marton, Jeno P ^c  

^a Health Economics and Outcomes Research   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^c PFIZER INC   (United States)

^d MN002 0258 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; COST OF ILLNESS; EMPLOYEE; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; WORK DISABILITY;

COHORT STUDIES; COMORBIDITY; DISABILITY EVALUATION; DISABLED PERSONS; EMPLOYMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 33846245458     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31802db55f     Document Type: Article

References (15)

1. Celli BR. MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-946.
2. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ. 2002;51:1-16.
3. Chronic Obstructive Pulmonary Disease: Data Fact Sheet. US Department of Health and Human Services, National Institutes of Health, NHLBI, NIH Publication 03-5229; March 2003.
4. World Health Organization. Chronic Respiratory Diseases: COPD. Available at: www.who.int/respiratory/copd/en/. Accessed December 2005.
5. Stahl E, Jansson SA, Jonsson AC, Svensson K, Lundbäck B, Andersson F. Health-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPD. Health Qual Life Outcomes. 2003;1:18.
6. Rennard S, Decramer M, Calverley PMA, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J. 2002;20:799-805.
7. Wouters EF. Economic analysis of the Confronting COPD survey: an overview of results. Respir Med. 2003;97(suppl C): S3-14.
8. Halpern MT, Stanford RH, Borker R. The burden of COPD in the USA: results from the confronting COPD survey. Respir Med. 2003;97(suppl C):S81-89.
9. Wang PS, Beck A, Berglund P, et al. Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveys. J Occup Environ Med. 2003;45:1303-1311.
10. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the 'top 10′ physical and mental health conditions affecting six large US employers in 1999. J Occup Environ Med. 2003;45:5-14.
11. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project. Clinical Classifications Software (CCS) for ICD-9-CM. Available at: www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp.
12. Celli BR. The importance of spirometry in COPD and asthma. Chest. 2000;117:15S-19S.
13. 1: the Lung Health Study. JAMA. 1994;272:1497-1505.
14. Javitz HS, Swan GE, Zbikowski SM, et al. Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer's perspective. Value in Health. 2004;7:535-543.
15. National Heart, Lung, and Blood Institute, World Health Organization. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (updated 2005). Available at: www.goldcopd.com. Accessed December 2005.